See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Alcon acquiring EVO ICLs in STAAR Surgical deal

Summary by Insight
It will allow Alcon to offer a surgical vision correction solution for those who are not ideal candidates for other refractive surgeries. Image: Konektus Photo/Shutterstock.com.Alcon is expanding its refractive surgery portfolio through a $1.5 billion (AU$2.3 b) acquisition of EVO implantable collamer lens (ICL) manufacturer STAAR Surgical Company. On 8 August 2025, the companies announced a definitive merger agreement through which Alcon intend…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

InsightInsight

Alcon acquiring EVO ICLs in STAAR Surgical deal

It will allow Alcon to offer a surgical vision correction solution for those who are not ideal candidates for other refractive surgeries. Image: Konektus Photo/Shutterstock.com.Alcon is expanding its refractive surgery portfolio through a $1.5 billion (AU$2.3 b) acquisition of EVO implantable collamer lens (ICL) manufacturer STAAR Surgical Company. On 8 August 2025, the companies announced a definitive merger agreement through which Alcon intend…

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Insight broke the news in on Tuesday, August 12, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Australia icon

Australia

News
For You
SearchBlindspotLocal